The oxytocic pharmaceuticals market revenue will touch US$ 98.60 million in 2021. Exhibiting a CAGR of 7.74 per cent between 2021 and 31, the market is expected to reach US$ 207.80 million by 2031, stated Future Market Insights (FMI).